Subacute sclerosing panencephalitis – current perspectives
Paediatrics and Child Health
Subacute sclerosing panencephalitis is a progressive neurodegenerative disease. It usually occurs 7–10 years after measles infection. The clinical course is characterized by progressive cognitive decline and behavior changes followed by focal or generalized seizures as well as myoclonus, ataxia, visual disturbance, and later vegetative state, eventually leading to death. It is diagnosed on the basis of Dyken’s criteria. There is no known cure for subacute sclerosing panencephalitis to date, but it is preventable by ensuring that an effective vaccine program for measles is made compulsory for all children younger than 5 years in endemic countries.
Pediatric Health, Medicine and Therapeutics
Jafri, S. K.,
Ibrahim, S. H.
(2018). Subacute sclerosing panencephalitis – current perspectives. Pediatric Health, Medicine and Therapeutics, 9, 67-71.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_women_childhealth_paediatr/386